MAPT and Alzheimer disease: The pathogenic mechanisms that lead to the clinical manifestation of AD are still debated, including two recognized hypotheses: the amyloid cascade hypothesis (Hardy and Allsop, 1991) and the tau hyperphosphorylation hypothesis (Wischik et al., 1988).